Inotiv Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Inotiv wird ein Gewinn- und Umsatzwachstum von 31.7% bzw. 7.2% pro Jahr prognostiziert, während der Gewinn pro Aktie um 33.6% pro Jahr wachsen soll.

Wichtige Informationen

31.7%

Wachstumsrate der Gewinne

33.6%

EPS-Wachstumsrate

Life Sciences Gewinnwachstum	17.5%
Wachstumsrate der Einnahmen	7.3%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	30 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Inotiv, Inc.'s (NASDAQ:NOTV) 57% Dip In Price Shows Sentiment Is Matching Revenues

Apr 26

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Mar 19

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Feb 13

Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Dec 18

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Dec 13

Headwaters Capital - Inotiv: Transformation Into A Critical Full-Service Contract Research Organization

May 25

Inotiv: Leading Mid-Market CRO Ups Its Game

Feb 07

Gewinn- und Umsatzwachstumsprognosen

NasdaqCM:NOTV - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
9/30/2027	616	N/A	58	N/A	1
9/30/2026	574	N/A	43	8	2
9/30/2025	527	-69	4	-1	3
9/30/2024	477	-115	-49	-9	2
6/30/2024	501	-99	-9	14	N/A
3/31/2024	553	-71	10	33	N/A
12/31/2023	585	-33	4	29	N/A
9/30/2023	572	-105	0	28	N/A
6/30/2023	582	-340	-17	9	N/A
3/31/2023	597	-345	-42	-4	N/A
12/31/2022	586	-341	-50	-11	N/A
9/30/2022	548	-337	-42	-5	N/A
6/30/2022	427	-83	-38	-3	N/A
3/31/2022	277	-77	-15	10	N/A
12/31/2021	156	-72	-9	8	N/A
9/30/2021	90	11	-2	11	N/A
6/30/2021	75	0	-2	8	N/A
3/31/2021	68	-4	0	5	N/A
12/31/2020	65	-4	-4	1	N/A
9/30/2020	60	-5	-5	1	N/A
6/30/2020	59	-3	-6	2	N/A
3/31/2020	55	-2	-7	1	N/A
12/31/2019	48	-2	-6	2	N/A
9/30/2019	44	-1	-5	2	N/A
6/30/2019	38	-1	-2	3	N/A
3/31/2019	33	-1	0	4	N/A
12/31/2018	30	0	2	4	N/A
9/30/2018	26	0	2	3	N/A
6/30/2018	23	0	1	2	N/A
3/31/2018	23	1	N/A	2	N/A
12/31/2017	23	1	N/A	1	N/A
9/30/2017	24	1	N/A	1	N/A
6/30/2017	24	-1	N/A	2	N/A
3/31/2017	23	-2	N/A	1	N/A
12/31/2016	22	-3	N/A	2	N/A
9/30/2016	20	-3	N/A	1	N/A
6/30/2016	20	-2	N/A	1	N/A
3/31/2016	21	0	N/A	2	N/A
12/31/2015	22	0	N/A	2	N/A
9/30/2015	23	1	N/A	2	N/A
6/30/2015	24	1	N/A	2	N/A
3/31/2015	24	0	N/A	1	N/A
12/31/2014	24	0	N/A	0	N/A
9/30/2014	25	-1	N/A	2	N/A
6/30/2014	24	0	N/A	1	N/A
3/31/2014	23	0	N/A	2	N/A
12/31/2013	22	0	N/A	2	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: NOTV wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: NOTV wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: NOTV wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: NOTVDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: NOTVDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von NOTV in 3 Jahren voraussichtlich hoch sein wird

Inotiv Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased by 70% to US$4.67

Inotiv, Inc. Withdraws Financial Guidance for Fiscal Year 2024

Consensus EPS estimates upgraded to US$1.15 loss

Price target increased by 22% to US$15.50

Inotiv, Inc. Reaffirms Earnings Guidance for the Fiscal 2024

Consensus EPS estimates fall by 18%

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Inotiv, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Inotiv, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Price target decreased by 70% to US$4.67

Inotiv, Inc. to Report Q3, 2024 Results on Aug 08, 2024

Inotiv, Inc. Withdraws Financial Guidance for Fiscal Year 2024

Inotiv, Inc. announced delayed 10-Q filing

Inotiv, Inc. to Report Q2, 2024 Results on May 10, 2024

Inotiv, Inc.'s (NASDAQ:NOTV) 57% Dip In Price Shows Sentiment Is Matching Revenues

New major risk - Share price stability

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates upgraded to US$1.15 loss

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Price target increased by 22% to US$15.50

An unknown buyer acquired RMS facilities in Spain and France from Inotiv, Inc. (NasdaqCM:NOTV).

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Reaffirms Earnings Guidance for the Fiscal 2024

Inotiv, Inc. to Report Q1, 2024 Results on Feb 07, 2024

Inotiv, Inc., Annual General Meeting, Mar 14, 2024

Consensus EPS estimates fall by 18%

Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Chief Operating Officer recently bought US$150k worth of stock

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Full year 2023 earnings: EPS misses analyst expectations

Inotiv, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Inotiv, Inc. to Report Q4, 2023 Results on Dec 11, 2023

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Inotiv, Inc. Announces Changes to Its Board Composition

Harlan Holdings Ltd. acquired Israeli Businesses from Inotiv, Inc. for $3.7 million.

Harlan Holdings Ltd. acquired Israeli Businesses from Inotiv, Inc. for $3.7 million.

New minor risk - Market cap size

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Revises Earnings Guidance for the Full Year 2023

Inotiv, Inc. to Report Q3, 2023 Results on Aug 10, 2023

New minor risk - Share price stability

Price target decreased by 12% to US$15.06

Inotiv, Inc.(NasdaqCM:NOTV) dropped from Russell Small Cap Comp Value Index

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Confirms Revenue Guidance for the Fiscal Year 2023

Is Inotiv (NASDAQ:NOTV) Using Debt In A Risky Way?

Price target increased by 91% to US$17.17

Inotiv, Inc. Reiterates Financial Guidance for the Fiscal Year Ending September 30, 2023

Inotiv, Inc. Reports Goodwill Impairment Charges for the First Quarter Ended December 31, 2022

Inotiv, Inc. to Report Q1, 2023 Results on Feb 13, 2023

Inotiv, Inc., Annual General Meeting, Mar 16, 2023

Inotiv, Inc. Announces Board Changes

Inotiv, Inc. Provides Revenue Guidance for the First Quarter and Second Quarter to Fourth Quarter and Earnings Guidance for the Full Year Fiscal 2023

Inotiv, Inc. to Report Q4, 2022 Results on Jan 10, 2023

Inotiv, Inc. announced delayed annual 10-K filing

Inotiv, Inc. Provides Revenue Guidance for the Fiscal Year 2022

Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S

Inotiv, Inc. to Report Q4, 2022 Results on Dec 12, 2022

Price target decreased to US$50.33

Price target decreased to US$50.33

Bronstein, Gewirtz & Grossman, LLC Notifies Investors That A Class Action Lawsuit Has Been Filed Against Inotiv, Inc

Inotiv, Inc. Revises Earnings Guidance for the Fiscal Year Ending September 30, 2022

Law Offices of Howard G. Smith Files Lawsuit Against Inotiv, Inc

Inotiv, Inc. to Report Q3, 2022 Results on Aug 10, 2022

Inotiv, Inc. Decides to Close Two of its Facilities, a Purpose-Bred Canine Facility in Cumberland, Virginia

Inotiv adds 16% on settlement with U.S. over Virginia facility

Inotiv, Inc. (NasdaqCM:NOTV) acquired Protypia, Inc. for $11 million.

Inotiv completes acquisition of bioanalytical company Protypia for ~$11M

Inotiv, Inc. Announces Retirement of James Harkness as Chief Operating Officer, Effective from September 30, 2022

Kirby McInerney LLP Announces Filing of Securities Class Action on Behalf of Inotiv, Inc. Investors

Inotiv, Inc. Appoints Glenn Washer as Group President, Safety Assessment

Price target decreased to US$57.00

Headwaters Capital - Inotiv: Transformation Into A Critical Full-Service Contract Research Organization

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations